Long-term continuation of methotrexate therapy in giant cell arteritis patients in clinical practice.

Objectives: To assess the long-term continuation of methotrexate (MTX) in a cohort of patients with giant cell arteritis (GCA) in daily clinical practice. Factors associated with its discontinuation rate were also investigated.

Methods: A longitudinal study from 1991-2014, was performed.